Loading chat...

NY A05029

Bill

Status

Introduced

2/11/2025

Primary Sponsor

Jonathan Jacobson

Click for details

Origin

Assembly

2025-2026 General Assembly

AI Summary

  • Allows pharmacists to substitute brand name epinephrine auto-injectors (like EpiPen) with alternate versions containing the same active ingredients, dosage, and strength, even if the alternate is not on the official interchangeable drug products list

  • Substitution is only permitted when the alternate device would cost less for the purchaser

  • Pharmacists must obtain the patient's consent before dispensing the alternate auto-injector

  • Pharmacists are required to counsel patients on proper usage and operating features of the alternate epinephrine auto-injector, since different devices may have different administration methods

  • Substitution is prohibited if the prescriber specifically indicates the prescription must be dispensed as written

Legislative Description

Relates to the substitution of brand name epinephrine auto-injectors with alternate epinephrine auto-injectors in certain cases.

Last Action

referred to higher education

1/7/2026

Committee Referrals

Higher Education2/11/2025

Full Bill Text

No bill text available